The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration

Keith Evans1, Simon K Law2, John Walt3, Patricia Buchholz4, Jan Hansen31Global Health Outcomes, Wolters Kluwer Health, Chester, United Kingdom; 2Jules Stein Eye Institute, Los Angeles, CA, USA; 3Global Health Outcomes Strategy and Research, Allergan Inc., Irvine, CA, USA; 4Health Economics, Pricing,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Keith Evans, Simon K Law, John Walt, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/82b90ef6f7024ca08fab26436c5febf7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:82b90ef6f7024ca08fab26436c5febf7
record_format	dspace
spelling	oai:doaj.org-article:82b90ef6f7024ca08fab26436c5febf72021-12-02T04:45:04ZThe quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration1177-54671177-5483https://doaj.org/article/82b90ef6f7024ca08fab26436c5febf72009-07-01T00:00:00Zhttp://www.dovepress.com/the-quality-of-life-impact-of-peripheral-versus-central-vision-loss-wi-a3396https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Keith Evans1, Simon K Law2, John Walt3, Patricia Buchholz4, Jan Hansen31Global Health Outcomes, Wolters Kluwer Health, Chester, United Kingdom; 2Jules Stein Eye Institute, Los Angeles, CA, USA; 3Global Health Outcomes Strategy and Research, Allergan Inc., Irvine, CA, USA; 4Health Economics, Pricing, and Reimbursement, Allergan GmbH, Ettlingen, GermanyPurpose: It is well accepted that conditions that cause central vision loss (CVL) have a negative impact on functional ability and quality of life (QoL), but the impact of diseases that cause peripheral vision loss (PVL) is less well understood. Focusing on glaucoma and age-related macular degeneration (ARMD), the effects of CVL and PVL on QoL were compared. Methods: A systematic literature review of publications reporting QoL in patients with CVL or PVL identified 87 publications using four generic (Short-Form Health Survey-36 and -12, EuroQoL EQ-5D and Sickness Impact Profile) and five vision-specific (National Eye Institute Visual Function Questionnaire-51, -39, and -25, Impact of Vision Impairment and Visual Function-14) QoL instruments; 33 and 15 publications reported QoL in ARMD and glaucoma, respectively.Results: QoL was impaired to a similar extent by diseases associated with PVL and CVL, but different domains were affected. In contrast to ARMD, mental aspects appeared to be affected more than physical aspects in patients with glaucoma.Conclusions: The differential impact upon QoL might be a function of the pathology of the diseases, for example potential for blindness and better ability to perform physical tasks due to retention of central vision may explain these observations in glaucoma.Keywords: vision loss, quality of life, glaucoma, age-related macular degeneration, diabetic macular edema, cataracts Keith EvansSimon K LawJohn Waltet alDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2009, Iss default, Pp 433-445 (2009)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Keith Evans Simon K Law John Walt et al The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
description	Keith Evans1, Simon K Law2, John Walt3, Patricia Buchholz4, Jan Hansen31Global Health Outcomes, Wolters Kluwer Health, Chester, United Kingdom; 2Jules Stein Eye Institute, Los Angeles, CA, USA; 3Global Health Outcomes Strategy and Research, Allergan Inc., Irvine, CA, USA; 4Health Economics, Pricing, and Reimbursement, Allergan GmbH, Ettlingen, GermanyPurpose: It is well accepted that conditions that cause central vision loss (CVL) have a negative impact on functional ability and quality of life (QoL), but the impact of diseases that cause peripheral vision loss (PVL) is less well understood. Focusing on glaucoma and age-related macular degeneration (ARMD), the effects of CVL and PVL on QoL were compared. Methods: A systematic literature review of publications reporting QoL in patients with CVL or PVL identified 87 publications using four generic (Short-Form Health Survey-36 and -12, EuroQoL EQ-5D and Sickness Impact Profile) and five vision-specific (National Eye Institute Visual Function Questionnaire-51, -39, and -25, Impact of Vision Impairment and Visual Function-14) QoL instruments; 33 and 15 publications reported QoL in ARMD and glaucoma, respectively.Results: QoL was impaired to a similar extent by diseases associated with PVL and CVL, but different domains were affected. In contrast to ARMD, mental aspects appeared to be affected more than physical aspects in patients with glaucoma.Conclusions: The differential impact upon QoL might be a function of the pathology of the diseases, for example potential for blindness and better ability to perform physical tasks due to retention of central vision may explain these observations in glaucoma.Keywords: vision loss, quality of life, glaucoma, age-related macular degeneration, diabetic macular edema, cataracts
format	article
author	Keith Evans Simon K Law John Walt et al
author_facet	Keith Evans Simon K Law John Walt et al
author_sort	Keith Evans
title	The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
title_short	The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
title_full	The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
title_fullStr	The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
title_full_unstemmed	The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
title_sort	quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
publisher	Dove Medical Press
publishDate	2009
url	https://doaj.org/article/82b90ef6f7024ca08fab26436c5febf7
work_keys_str_mv	AT keithevans thequalityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration AT simonklaw thequalityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration AT johnwalt thequalityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration AT etal thequalityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration AT keithevans qualityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration AT simonklaw qualityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration AT johnwalt qualityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration AT etal qualityoflifeimpactofperipheralversuscentralvisionlosswithafocusonglaucomaversusagerelatedmaculardegeneration
_version_	1718401090314043392

The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration

Ejemplares similares